INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
EM
ElAssir MahmoudDirector
RNGRingCentral, Inc.
Grant or award
A—
10.1K sh
Jan 2, 2026Jan 5, 2026
Page 1584 of 1855
← PrevNext →
traded Jan 2, 2026
+3d
SEC Form 4

Evidence

9
DL
DiRico Jennifer LeighEVP, Chief Financial Officer
PTCPTC INC.
Grant or award
A—
7,892 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

9
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Option exercise
M—
764 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

9
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise
M—
612 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

9
PA
Pande AbhayDirector
ZSPCzSpace, Inc.
Option exercise
M—
3,361 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

9
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Tax withholding
F$23K
2,253 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

9
WD
Williams Jeremy D.Chief Actuary
CNOCNO Financial Group, Inc.
Tax withholding
F$32K
748 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

9
JS
Jain Amit SDirector
ZSPCzSpace, Inc.
Option exercise
M—
3,361 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

8
EA
Ehlers Paul ACOO - City Bank
SPFISOUTH PLAINS FINANCIAL, INC.
Tax withholding · 10b5-1 plan
F$97K
2,447 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

7
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
310 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

7
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M—
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

6
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
600 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

6
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M$102K
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

5
AY
Agiri Oluwagbemileke YusufCFO
GEVOGevo, Inc.
Grant or award
A—
10.0K sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

5
EA
Ehlers Paul ACOO - City Bank
SPFISOUTH PLAINS FINANCIAL, INC.
Option exercise · 10b5-1 plan
M—
6,000 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

5
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise
M—
781 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

5
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Tax withholding
F$6,201
748 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

5
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Option exercise
M—
4,834 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

5
WG
Whalen Thomas GerardDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$2,505
131 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
175.7K sh
Jan 5, 2026Jan 5, 2026
traded Jan 5, 2026
+0dSEC Form 4

Evidence

5
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Tax withholding
F$8,821
1,064 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
346.1K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

5
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise
M—
612 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

5
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Tax withholding
F$5,803
700 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

5
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise
M—
551 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

3
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
310 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

3
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Tax withholding · 10b5-1 plan
F$9,628
116 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

48
AE
Allison EricChief Product Officer
JOBYJoby Aviation, Inc.
Open-market sale
SELL$430K
32.4K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

46
MP
Manulife (Singapore) Pte. Ltd.10% Owner
NANAJohn Hancock GA Mortgage Trust
Open-market purchase
BUY$16.00M
860.3K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

45
MH
Mountain Crest Global Holdings LLC10% Owner
MCAGUMountain Crest Acquisition Corp. V
Open-market sale
SELL$1.00M
200.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

45
LS
Liu SuyingDirector, CEO and CFO, 10% Owner
MCAGUMountain Crest Acquisition Corp. V
Open-market sale
SELL$1.00M
200.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

41
TN
Thompson Michael N. Jr.Director
JOBYJoby Aviation, Inc.
Open-market purchase
BUY$7,282
550 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

41
TN
Thompson Michael N. Jr.Director
JOBYJoby Aviation, Inc.
Open-market purchase
BUY$7,282
550 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

40
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$37K
2,714 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

40
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$20K
1,462 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

40
DS
Dhaliwal Harpreet S.Chief Technical Ops Officer
PCVXVaxcyte, Inc.
Open-market sale
SELL$455K
9,743 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

39
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$111K
8,072 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

39
MB
Manufacturers Life Insurance Co (Bermuda Branch)10% Owner
NANAJohn Hancock GA Mortgage Trust
Open-market purchase
BUY$5.00M
268.8K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

38
Ehikian Stephen BradleyChief Executive Officer
AIC3.ai, Inc.
Open-market sale
SELL$3.19M
234.9K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

36
WM
Winter Charles M.Chief Technical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$33K
2,401 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence